Skip to content
Insider tapeFilings through Fri, Oct 9
Watchlist

David Charles Lubner

Director at Braveheart Bio, Inc. (BRVE)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys+$112K
Total bought / sold$1000K / $0

Reported trades

Filed Stock Type Shares Price Value Since
Aug 7SEC BRVEBraveheart Bio, Inc. Buy 55,555new position $18.00 $1000K +11.2%
  • Buy

    Director David Charles Lubner bought $1000K of BRVE at $18.00 — first open-market purchase in our records; opens a new position.